Blood Work: κ light chain–expressing hematogones in a patient with λ-restricted CLL and multiple myeloma on daratumumab therapy loom.ly/CPTvJ5A

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy loom.ly/fNtvVdQ #myeloidneoplasia

A model of painful vaso-occlusive crisis in mice with sickle cell disease loom.ly/D8SQW9I #SCD

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell #lymphoma loom.ly/Mbvl_Z8

Antigen-guided depletion of anti-HLA antibody–producing cells by HLA-Fc fusion proteins loom.ly/63jRfc8 #immunobiology #immunotherapy

Blood Work: Multiple myeloma presenting with extracellular crystal deposition in the bone marrow loom.ly/_U8ZUzE #mmsm

Topics from this week's podcast episode include lenalidomide and subsequent TP53-mutated myeloid neoplasms, abnormal uterine bleeding after #VTE , and novel tri-specific antibody for B-ALL loom.ly/5jf2ADE

The newest issue of Blood is now available loom.ly/7_a1Gzo #hematology

GGCX mutants that impair hemostasis reveal the importance of processivity and full carboxylation to VKD protein function loom.ly/wL6BDFA